Affiliation:
1. Division of Cardiovascular Medicine and Cardiovascular Institute Stanford University Stanford CA USA
2. Veterans Affairs Palo Alto Healthcare System Palo Alto CA USA
3. Palo Alto Medical Foundation Palo Alto CA USA
4. Department of Medicine Stanford University Stanford CA USA
Abstract
Background
Asian and multiracial individuals represent the 2 fastest growing racial and ethnic groups in the United States, yet most prior studies report Asian American and Native Hawaiian or Other Pacific Islander as a single racial group, with limited data on cardiovascular disease (CVD) prevalence among subgroups. We sought to evaluate temporal trends in CVD burden among disaggregated Asian subgroups.
Methods and Results
Patients with CVD based on
International Classification of Diseases, Ninth Revision
and
Tenth Revision
(
ICD‐9
and
ICD‐10
) coding who received care from a mixed‐payer health care organization in California between 2008 and 2018 were classified into self‐identified racial and ethnic subgroups (non‐Hispanic White [NHW], Asian Indian, Chinese, Filipino, Japanese, Korean, Native Hawaiian or Other Pacific Islander, and multiracial groups). Adjusted trends in CVD prevalence over time by subgroup were compared using logistic regression. Among 3 494 071 patient‐years, prevalence of CVD increased faster among all subgroups except Japanese and Native Hawaiian or Other Pacific Islander patients (
P
<0.01 for each, reference: NHW). Filipino patients had the highest overall CVD prevalence, which increased from 34.3% to 45.1% over 11 years (increase from 17.3%–21.9%,
P
<0.0001, reference: NHW). Asian Indian patients had the fastest increase in CVD prevalence over time (16.9%–23.7%,
P
<0.0001, reference: NHW). Among subcategories of disease, hypertension increased faster among Asian Indian, Chinese, Filipino, Korean, and multiracial groups (
P
<0.01 for all, reference: NHW), and coronary artery disease increased faster among Asian Indian, Chinese, Filipino, and Japanese groups (
P
<0.05 for each, reference: NHW).
Conclusions
The increasing prevalence of CVD among disaggregated Asian, Native Hawaiian or Other Pacific Islander, and multiracial subgroups over time highlights the importance of tailored approaches to addressing CVD in these diverse subpopulations.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference65 articles.
1. Budiman A Ruiz NG. Key Facts About Asian Origin Groups in the U.S. Pew Research Center; 2021. Published May 22 2019. Updated September 8 2021. Accessed October 19 2021. https://www.pewresearch.org/fact‐tank/2021/04/29/key‐facts‐about‐asian‐origin‐groups‐in‐the‐u‐s/
2. Health Disparities Among Asian Americans and Pacific Islanders
3. Jones N Marks R Ramirez R Río‐Vargas M Bureau UC. Census Illuminates Racial and Ethnic Composition of the Country. United States Census Bureau; 2020. Published August 12 2021. Accessed October 19 2021. https://www.census.gov/library/stories/2021/08/improved‐race‐ethnicity‐measures‐reveal‐united‐states‐population‐much‐more‐multiracial.html
4. Monte LM Shin HB. 20.6 Million People in the U.S. Identify as Asian Native Hawaiian or Pacific Islander. United States Census Bureau. Published May 25 2022. Accessed July 5 2022. https://www.census.gov/library/stories/2022/05/aanhpi‐population‐diverse‐geographically‐dispersed.html
5. Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献